NTLA Operating Cash Flow Growth
Intellia Therapeutics Inc · Operating Cash Flow Growth
NTLA Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported17.19%period ending
NTLA TTM Cash from Operations YoY % (1059.76% → 17.19%)
Year-over-year change
High-resolution chart · PNG
NTLA operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 17.1868% | |
| 3.711% | |
| -13.1438% | |
| -15.111% | |
| -12.1358% | |
| 6.9735% | |
| 11.4711% | |
| 8.7393% | |
| -1.4229% | |
| -11.7432% | |
| -18.2422% | |
| -31.1445% | |
| -29.3364% | |
| -43.7143% | |
| -48.1078% | |
| -41.5299% | |
| -63.4107% | |
| -296.0513% | |
| -350.8535% | |
| -449.1942% | |
| -394.1853% | |
| 47.0274% | |
| 51.6544% | |
| 53.8621% | |
| 49.7476% | |
| -85.2972% | |
| -68.5358% | |
| -12.281% | |
| 10.6328% | |
| 9.3624% | |
| 6.1569% | |
| -26.7986% | |
| -59.8195% | |
| -309.9144% | |
| -280.7749% | |
| -229.6527% | |
| -199.443% | |
| 313.245% | |
| 2,148.1566% | |
| 4,429.9799% | |
| 1,059.7604% |